Tunisie-Tribune ( Frost & Sullivan Reveals Healthcare ) – In 2019, GCC countries will represent 13% of global revenues for healthcare products, with services growing at 12%. The region is witnessing increasing demand for healthcare services, largely driven by increased prevalence of chronic diseases and improved healthcare.
While turmoil in oil prices continues, public health expenditure remains a priority for governments. The private sector will play a key role by entering into public-private partnerships. The rising demand for better healthcare services in the region and global advancements in medical technologies have opened up a number of opportunities for information technology (IT) organisations to tap into this growing sector. Technologies such as blockchain, wearables, internet of medical things and artificial intelligence will play a key role in the future of the sector.
“Local production of generic pharmaceuticals is expected to create major opportunities, thereby boosting the regional economy through job creation, reduced unemployment, and increased export capacity in the GCC countries,” says Reenita Das, Partner & Senior Vice President, Transformational Health, Frost & Sullivan. “Though digital health is still at a nascent stage, the start-up entrepreneurial culture is emerging quickly, opening up growth opportunities for telehealth and artificial intelligence”.
In this context, Frost & Sullivan will host an interactive GIL Council Meeting on 24th April and will discuss views on 2019 Healthcare Opportunities, Predictions, Outlook, and Challenges in the GCC countries. The event will be attended by CXOs and senior management from hospitals, pharmaceutical and medical technology firms across UAE.
Key takeaways from the session:
- Gain insights into the healthcare market’s predictions for 2019 in GCC countries and critical issues affecting the healthcare industry globally.
- Learn how the convergence of cutting-edge technology such as artificial intelligence, big data, Cloud, and blockchain will help shape the healthcare industry into a much-anticipated, value-based care paradigm.
- Identify new opportunities connected to the pharmaceutical, biotechnology, medical technologies, diagnostics, medical imaging, and healthcare IT sectors.
- Better understand which investments will pay off in terms of productivity, efficiency and better outcomes for patients in 2019 and beyond.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion